Speaker illustration

Doctor Joseph Kassab

UT Southwestern Medical Center, Dallas (United States of America)

Member of:

European Society of Cardiology

Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction

Event: ESC Congress 2025

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: HFpEF issues

Thumbnail

Direct oral anticoagulants versus warfarin for left ventricular thrombus

Event: ESC Congress 2025

Topic: Anticoagulants

Session: Unmet needs in anticoagulant pharmacotherapy

Thumbnail

Liraglutide in patients with heart failure with preserved ejection fraction and obesity without diabetes

Event: ESC Congress 2025

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Therapeutic strategies for HFpEF

Thumbnail

Catheter ablation for atrial fibrillation in patients with heart failure with preserved ejection fraction

Event: ESC Congress 2025

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Therapeutic strategies for HFpEF

Thumbnail

Long term outcomes of surgical versus transcatheter aortic valve replacement in bicuspid aortic valve stenosis

Event: ESC Congress 2025

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation: outcomes, complications, and adjunctive therapy

Thumbnail

Assessing the accuracy of an online chat-based artificial intelligence model in providing recommendations on arterial hypertension in accordance with the 2018 ESC/ESH guidelines

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Lifestyle and intention in hypertension

Thumbnail

Outcomes following permanent pacemaker implantation in patients undergoing tricuspid valve surgery

Event: ESC Congress 2023

Topic: Valves

Session: Structural heart valve disease treated: a look behind the curtain of time

Thumbnail

Incidence and risk factors for permanent pacemaker implantation in patients undergoing tricuspid valve surgery

Event: ESC Congress 2023

Topic: Valves

Session: Structural heart valve disease treated: a look behind the curtain of time

Thumbnail